| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Tiantian Guo, Qingchao Liu, Pengbo Hou, Fahui Li, Shoudong Guo, Weiguo Song, Hai Zhang, Xueying Liu, Shengyong Zhang, Jianchun Zhang, Chi-Tang Ho, Naisheng Ba. Stilbenoids and cannabinoids from the leaves of Cannabis sativa f. sativa with potential reverse cholesterol transport activity. Food & function. vol 9. issue 12. 2019-04-03. PMID:30500001. |
three new stilbenoids (1-3) and 16 known stilbenoids (4-6) and cannabinoids (7-19) were isolated from the leaves of hemp (cannabis sativa l.). |
2019-04-03 |
2023-08-13 |
human |
| Philip Hsiao, Raul I Clavij. Adverse Effects of Cannabis on Male Reproduction. European urology focus. vol 4. issue 3. 2019-04-01. PMID:30146239. |
in this mini-review, we highlight the known effects of cannabis on clinical markers of male fertility potential and review the role of the endocannabinoid system as it pertains to sex hormone and sperm production, as well as sperm function. |
2019-04-01 |
2023-08-13 |
Not clear |
| Marco Colizzi, Sagnik Bhattacharyy. Neurocognitive effects of cannabis: Lessons learned from human experimental studies. Progress in brain research. vol 242. 2019-03-29. PMID:30471680. |
the following chapter offers an overview of results of experimental studies conducted among healthy individuals examining the effects of acute administration of Δ9-thc and other cannabinoids, alone or in combination, on brain function and behavior, also as a function of previous cannabis exposure. |
2019-03-29 |
2023-08-13 |
human |
| Marianne Hädener, Michael Z Kamrath, Wolfgang Weinmann, Michael Groess. High-Resolution Ion Mobility Spectrometry for Rapid Cannabis Potency Testing. Analytical chemistry. vol 90. issue 15. 2019-03-26. PMID:29943977. |
we analyzed cannabis extracts by electrospray ionization ims-ms and found that high-resolution drift-tube ims ( r > 150) can effectively isolate and quantify the controlled substance, Δ9-tetrahydrocannabinol (thc), even in the presence of other noncontrolled cannabinoid isomers including cannabidiol (cbd). |
2019-03-26 |
2023-08-13 |
Not clear |
| Gabrielle Campbell, Wayne D Hall, Amy Peacock, Nicholas Lintzeris, Raimondo Bruno, Briony Larance, Suzanne Nielsen, Milton Cohen, Gary Chan, Richard P Mattick, Fiona Blyth, Marian Shanahan, Timothy Dobbins, Michael Farrell, Louisa Degenhard. Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study. The Lancet. Public health. vol 3. issue 7. 2019-03-25. PMID:29976328. |
interest in the use of cannabis and cannabinoids to treat chronic non-cancer pain is increasing, because of their potential to reduce opioid dose requirements. |
2019-03-25 |
2023-08-13 |
Not clear |
| Shani Poleg, Pavel Golubchik, Daniel Offen, Abraham Weizma. Cannabidiol as a suggested candidate for treatment of autism spectrum disorder. Progress in neuro-psychopharmacology & biological psychiatry. vol 89. 2019-03-25. PMID:30171992. |
there is increasing interest in cannabinoids, especially cannabidiol (cbd), as monotherapy or add-on treatment for the core symptoms and co-morbidities of asd. |
2019-03-25 |
2023-08-13 |
Not clear |
| E Alfonso Romero-Sandoval, Jack E Fincham, Ashley L Kolano, Brandi N Sharpe, P Abigail Alvarado-Vázque. Cannabis for Chronic Pain: Challenges and Considerations. Pharmacotherapy. vol 38. issue 6. 2019-03-22. PMID:29637590. |
the national academies of sciences, engineering, and medicine has found substantial evidence that cannabis (plant) is effective for the treatment of chronic pain in adults, and moderate evidence that oromucosal cannabinoids (extracts, especially nabiximols) improve short-term sleep disturbances in chronic pain. |
2019-03-22 |
2023-08-13 |
Not clear |
| E Alfonso Romero-Sandoval, Jack E Fincham, Ashley L Kolano, Brandi N Sharpe, P Abigail Alvarado-Vázque. Cannabis for Chronic Pain: Challenges and Considerations. Pharmacotherapy. vol 38. issue 6. 2019-03-22. PMID:29637590. |
the paradoxical superiority of the cannabis plant over cannabinoid molecules represents a challenge for the medical community and the established processes that define modern pharmacy. |
2019-03-22 |
2023-08-13 |
Not clear |
| Kevin P Hill, Matthew D Palastr. Medical cannabis for the treatment of chronic pain and other disorders: misconceptions and facts. Polish archives of internal medicine. vol 127. issue 11. 2019-03-21. PMID:29067992. |
while cannabis and cannabinoids continue to be evaluated as pharmacotherapy for medical conditions, the best evidence currently exists for the following medical conditions: chronic pain, neuropathic pain, and spasticity resulting from multiple sclerosis. |
2019-03-21 |
2023-08-13 |
Not clear |
| Kevin P Hill, Matthew D Palastr. Medical cannabis for the treatment of chronic pain and other disorders: misconceptions and facts. Polish archives of internal medicine. vol 127. issue 11. 2019-03-21. PMID:29067992. |
we also reviewed the current state of evidence for cannabis and cannabinoids for several other medical conditions, while addressing the potential acute and chronic effects of cannabis use, which are issues that physicians must consider before making an official recommendation on the use of medical cannabis to a patient. |
2019-03-21 |
2023-08-13 |
Not clear |
| Marcel O Bonn-Miller, Mahmoud A ElSohly, Mallory J E Loflin, Suman Chandra, Ryan Vandre. Cannabis and cannabinoid drug development: evaluating botanical versus single molecule approaches. International review of psychiatry (Abingdon, England). vol 30. issue 3. 2019-03-21. PMID:30179534. |
cannabis and cannabinoid drug development: evaluating botanical versus single molecule approaches. |
2019-03-21 |
2023-08-13 |
Not clear |
| Marcel O Bonn-Miller, Mahmoud A ElSohly, Mallory J E Loflin, Suman Chandra, Ryan Vandre. Cannabis and cannabinoid drug development: evaluating botanical versus single molecule approaches. International review of psychiatry (Abingdon, England). vol 30. issue 3. 2019-03-21. PMID:30179534. |
this commentary discusses the unique challenges and merits of botanical vs single molecule cannabinoid drug development strategies, highlights how both can be impacted by legalization of cannabis via legislative processes, and also addresses regulatory and public health considerations that are important to consider as cannabinoid medicine advances as a discipline. |
2019-03-21 |
2023-08-13 |
Not clear |
| Lauren Hoo. Social Factors and Animal Models of Cannabis Use. International review of neurobiology. vol 140. 2019-03-21. PMID:30193704. |
typically smoked, vaporized or ingested orally, cannabis is used primarily for recreational purposes, though a few synthetic cannabinoids have been approved for medicinal treatments. |
2019-03-21 |
2023-08-13 |
Not clear |
| Lauren Hoo. Social Factors and Animal Models of Cannabis Use. International review of neurobiology. vol 140. 2019-03-21. PMID:30193704. |
psychoactive cannabinoids, or the pharmacologically active compounds within cannabis, are responsible for producing the infamous "high" sensation, characterized by feelings of euphoria and relaxation, though can also provoke hallucinations, paranoia and anxiety. |
2019-03-21 |
2023-08-13 |
Not clear |
| Lauren Hoo. Social Factors and Animal Models of Cannabis Use. International review of neurobiology. vol 140. 2019-03-21. PMID:30193704. |
while the field has made great strides in elucidating the mechanisms involved in behavioral pharmacology cannabinoids, the social aspects of cannabis use remains underrepresented in animal models. |
2019-03-21 |
2023-08-13 |
Not clear |
| Aaron C Elkins, Myrna A Deseo, Simone Rochfort, Vilnis Ezernieks, German Spangenber. Development of a validated method for the qualitative and quantitative analysis of cannabinoids in plant biomass and medicinal cannabis resin extracts obtained by super-critical fluid extraction. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. vol 1109. 2019-03-21. PMID:30738340. |
development of a validated method for the qualitative and quantitative analysis of cannabinoids in plant biomass and medicinal cannabis resin extracts obtained by super-critical fluid extraction. |
2019-03-21 |
2023-08-13 |
Not clear |
| Aaron C Elkins, Myrna A Deseo, Simone Rochfort, Vilnis Ezernieks, German Spangenber. Development of a validated method for the qualitative and quantitative analysis of cannabinoids in plant biomass and medicinal cannabis resin extracts obtained by super-critical fluid extraction. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. vol 1109. 2019-03-21. PMID:30738340. |
this study aims to bridge the gap between current methods of analysis for biomass and the final therapeutic product by describing a fully developed and validated ultra-high-performance-liquid-chromatography method with diode array detection (uhplc-dad) for the qualification and quantification of the cannabinoids cbda, cbd, cbn, thc, cbc and thca, in medicinal cannabis biomass and resin obtained by super-critical fluid extraction (sfe). |
2019-03-21 |
2023-08-13 |
Not clear |
| Lubertus Bijlsma, Rubén Gil-Solsona, Félix Hernández, Juan Vicente Sanch. What about the herb? A new metabolomics approach for synthetic cannabinoid drug testing. Analytical and bioanalytical chemistry. vol 410. issue 21. 2019-03-20. PMID:29909458. |
synthetic cannabinoids (scs) are consumed as legal alternative to cannabis and often allow passing drug-screening tests. |
2019-03-20 |
2023-08-13 |
human |
| Darren Reithmeier, Richard Tang-Wai, Blair Seifert, Andrew W Lyon, Jane Alcorn, Bryan Acton, Scott Corley, Erin Prosser-Loose, Darrell D Mousseau, Hyun J Lim, Jose Tellez-Zenteno, Linda Huh, Edward Leung, Lionel Carmant, Richard J Huntsma. The protocol for the Cannabidiol in children with refractory epileptic encephalopathy (CARE-E) study: a phase 1 dosage escalation study. BMC pediatrics. vol 18. issue 1. 2019-03-20. PMID:29981580. |
physicians show reluctance to recommend cannabis extracts given the lack of high quality safety data especially regarding the potential for harm caused by other cannabinoids, such as Δ |
2019-03-20 |
2023-08-13 |
Not clear |
| Michael B Gatch, Michael J Forste. Cannabinoid-like effects of five novel carboxamide synthetic cannabinoids. Neurotoxicology. vol 70. 2019-03-18. PMID:30439379. |
a new generation of novel cannabinoid compounds have been developed as marijuana substitutes to avoid drug control laws and cannabinoid blood tests. |
2019-03-18 |
2023-08-13 |
mouse |